Effectiveness, acceptability, adherence, and safety of exergaming for depressive symptoms: a systematic review and meta-analysis

• by Di Tang, Chang Liu, Jinde Liu, Tong Liu, Ruisi Ma, Kim-wai Raymond Sum

• February 25, 2026

GLP-1 Drugs Tied to Lower Addiction Risk

In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.

• by Kathryn Wighton

• May 27, 2026

• 5 min

What if I needed help? Population preferences for first-line mental health treatments in the post-COVID time

• by Voderholzer, Ulrich , Wuttke, Eva P., Baumeister, Anna , Zisler, Eva M., Jelinek, Lena

• May 15, 2026

Sex as a moderator of the relationship between childhood trauma and depression in adulthood: an analysis in a clinical sample of adult patients

• by Sylwia Michałowska, Magdalena Chęć, Wioletta Radziwiłłowicz

• May 20, 2026